Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Hims & Hers Health Says Are In Active Discussions To Make Wegovy Injections And Novo Nordisk's Oral Wegovy Available Through Hims & Hers Platform

Author: Benzinga Newsdesk | November 03, 2025 04:11pm

Discussions with Novo Nordisk

Hims & Hers and Novo Nordisk are in active discussions to make Wegovy injections and Novo Nordisk's oral Wegovy (when FDA approved) available through the Hims & Hers platform, advancing consumer options and pursuant to prescriber recommendation. Hims & Hers notes that discussions are ongoing, no definitive agreement has been executed with Novo Nordisk, and there is a possibility that no definitive agreement may ever be executed with Novo Nordisk. In addition, to the extent that a definitive agreement is executed, those terms may differ from what is currently anticipated. While Hims & Hers may voluntarily disclose the terms of any definitive agreement if and when it is executed, depending on the contours of such agreement, Hims & Hers may be under no legal obligation to do so.

Posted In: HIMS NVO

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist